Reduced expression of the inhibitory genes for fas-mediated apoptosis in silicosis patients

Journal of Occupational Health

Volumn 42, Issue 4, 2000, Pages 163-168

  Otsuki, T ^a   Tomokuni, A ^a   Sakaguchi, H ^a   Hyodoh, F ^a   Kusaka, M ^a   Ueki, A ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Autoimmunity; Fas mediated apoptosis; Inhibitory gene; mRNA; Silicosis

Indexed keywords

FAS ANTIGEN; MESSENGER RNA;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MONONUCLEAR CELL; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SILICOSIS;

EID: 0033857471     PISSN: 13419145     EISSN: None     Source Type: Journal    
DOI: 10.1539/joh.42.163     Document Type: Article

References (36)

1. Silica exposure and autoimmune diseases
2. Silica, silicosis, and progressive systemic sclerosis
3. Immunotoxicology of silica
4. Silica-associated connective tissue disease. A study of 24 cases
5. Silica induced scleroderma-clinical and experimental aspects
6. Silica-induced lupus erythematosus
7. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica
8. Elevated soluble Fas/APO-1(CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours
9. Elevated soluble Fas levels in patients with silicosis
10. Soluble Fas mRNA is dominantly expressed in cases with silicosis
11. Soluble Fas message is dominantly expressed in cases with silicosis
12. Serum levels of soluble Fas ligand in patients with silicosis
13. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients
14. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus
15. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases
16. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases
17. Fas (CD95)- transduced signal preferentially stimulates lupus peripheral T lymphocytes
18. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells
19. Inhibition of Fas death signals by FLIPs
20. Caspases: Key mediators of apoptosis
21. Caspases: Enemies within
22. The role of caspases in apoptosis
23. Death domain receptors and their role in cell demise
24. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
25. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45
26. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor
27. Cytosolic nuclease activated by caspase-3 and inhibited by DFF-45
28. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis
29. The role of silica compounds in the autoimmune diseases accompanied by silicosis
30. Activation of human CD4+CD45RA+ T cells by chrysotile asbestos in vitro
31. + lymphocytes can be stimulated by crocidolite, anthophyllite and amosite asbestos in vitro
32. Polyclonal human T-cell activation by silicate in vitro
33. Analysis of the expression of TCR Vβ repertoires in patients with silicosis
34. Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro
35. Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis
36. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes